2023
DOI: 10.1016/j.redox.2022.102562
|View full text |Cite
|
Sign up to set email alerts
|

Sulfide:quinone oxidoreductase ameliorates neurodegeneration in a murine model of Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 63 publications
0
1
0
Order By: Relevance
“…The same group demonstrate that CBS also promotes pseudohypoxia leading to a shift from oxidative phosphorylation to glycolysis and therefore to decreased mitochondrial ATP production in this disease, representing another example for the regulatory roles of sulfide in cellular bioenergetics [ 18 ]. In Parkinson's disease, increased activity of sulfide:quinone oxidoreductase, responsible for the oxidation of sulfide, diminish neurodegeneration in a murine model by Nagashima et al [ 19 ]. In contrast, in Alzheimer's disease, Rao et al show that stimulation of the H 2 S-producing enzyme 3-mercaptopyruvate sulfurtransferase (3MST) reduces oxidative stress and ameliorates disease pathology [ 20 ].…”
mentioning
confidence: 99%
“…The same group demonstrate that CBS also promotes pseudohypoxia leading to a shift from oxidative phosphorylation to glycolysis and therefore to decreased mitochondrial ATP production in this disease, representing another example for the regulatory roles of sulfide in cellular bioenergetics [ 18 ]. In Parkinson's disease, increased activity of sulfide:quinone oxidoreductase, responsible for the oxidation of sulfide, diminish neurodegeneration in a murine model by Nagashima et al [ 19 ]. In contrast, in Alzheimer's disease, Rao et al show that stimulation of the H 2 S-producing enzyme 3-mercaptopyruvate sulfurtransferase (3MST) reduces oxidative stress and ameliorates disease pathology [ 20 ].…”
mentioning
confidence: 99%